We describe a rapid radioimmunoassay for human placental lactogen inbiological fluids, withuse ofpolyethylene glycol to separate free from antibody-bound placental lactogen. The standard curve obtained, easily fitted to a logit-log transformation,is useful over a concentration range of 6 to 400 ug/liter. Within-assay variability is 1.97%, between-assay variability 2.20%. The relation is linear when lactogen added is plotted against that accounted for analytically, the actual recovery being
of the human placenta.2 Its production increases throughout normal gestation in a characteristic pattern, which is altered in certain trophoblastic disorders. Accordingly, its concentrations in maternal serum may serve as an index of placental function (1) . In addition, hPL is sometimes synthesized ectopically by non-trophoblastic tumors. Several RIA methods for the measurement of hPL have been previously described. Beck et al. (2) used a double antibody method for separation of free from antibody-bound hormone, while Saxena et al. (3), used dextran-coated charcoal. Chromatoelectrophoresis was used by Grumbach and Kaplan (4), and Letchworth et al. (5) used ethanol precipitation. Other methods have included ammonium sulfate precipitation (5) and solid-phase radioimmunoassay (6) . It has beenreported previously that polyethylene glycol is useful for separating free and antibody-bound peptide hormones in radioimmunoassays (7) . Aqueous polyethylene glycol (PEG) causes the precipitation of antibody-bound hormone, while unbound antigen remains free in solution.
Our studies on hPL synthesis and secretion in vitro required that we have a rapid and reliable method for the radioimmunoassay of hPL. Because the polyethylene glycol method of RIA had been successfully appliedto hormones of low relative molecular mass, such as insulin, somatotropin, and vasopressin (7), we extended this technique to the separation of free from antibody-bound hPL. This report describes the characteristics of the assay for the measurement of hPL concentrations in serum, plasma, and buffer. A straight-line plot for the standard curve is obtained by using the logit-log transformation. Procedure for assay of hPL. All tests were run in duplicate in 12 X 75 mm polypropylene test tubes, according to the protocol indicated in Table 1 . After addition of antisera the contents of the tubes are vortex-mixed and incubated at 37 #{176}C for 30 5 mm. After incubation, 260 g/liter PEG at 4 #{176}C is added and the contents of each tube are vigorously vortexmixed for 5s. The tubes are then centrifuged at 4#{176}C, 6000X g for 10 mm. The tubes should be centrifuged within 30 mm after PEG is added. The supernates are then aspirated, taking care to remove all liquid from the tube, and the radioactivity in the precipitates is counted.
Results and Discussion
Optimization of plasma concentration. Figure 1 shows the amount of radioactivity precipitated specifically and nonspecifically as a function of plasma concentration in the buffer. Consideration of several factors led us to choose a carrier plasma concentration of 100 ml/liter of buffer. First, a sufficient amount of carrier immunoglobulin needs to be present to completely precipitate the hPL antibody-bound complex by PEG while minimizing nonspecific precipitation of free I Vortex-mix and incubate for 30 mm at 37 #{176}C at this step.
Vortex-mix vigorously for 6 s, centrifuge (6000 X g, 10 mm), aspirate the eupernate, and count the residue.
Antibodypreclptot.d
Counts are diluted 100-fold for assay, they contribute a very small immunoglobulin increment when the carrier plasma concentration is high. Second, a high protein concentration gives a large, easily visible pellet, from which the supernate can be more efficiently removed. It is evident from Figure 1 that, at a plasma concentration of 100 mI/liter, precipitation of the antibody-bound complex is complete, and that nonspecific precipitation is relatively low.
Determination of hPL concentration in biological fluids.
Standard curves plotted two different ways are shown in Figures 2 and 3 . In both, the ordinate (B/B0 X 100) is shown as a percentage of the counts bound when a known amount of hPL (0 to 400 Mg/liter), designated B, is added to the assay mixture relative to the counts bound by the antibody control or zero standard (containing no added unlabeled hPL), designated Ru. In each case,the counts for nonspecific precipitation or blank are first subtracted from the counts bound by each standard (B) and the zero standard (Bo). The "total counts control" tube is included with each assay to determine if 45% of the total counts present are being bound by the antibody control, B0,after correcting for nonspecific precipitation. Figure 2 is the simplest representation of the standard 
Specificity of the antisera.
Rabbit antisera to hPL cross reacts to some extent with the structurally related peptide hormone, human somatotropin (8, 9) . However, the impor. tance of this cross reaction is minimized because the sensitivity of the antisera to hPL is 1000-10,000 times greater than to human somatotropin (10) . In addition, the concentration of hPL in pregnancy sera is more than 100-fold the somatotropin concentration. Recovery data. Fifty microliters of a 100-fold dilution of patient serum was added to 50 ul each of a set of hPL standards. A standard curve was constructed for determination of the hPL concentration in 100 ul of this diluted serum and also of the iOO-ul serum-standard combination.
The recovery results are shown in Table 2 . The average recovery was 100.26%. All samples were run in duplicate. A plot of these data, shows the relation to be linear, with a slope of 0.985, and a correlation coefficient, r, of 0.9987.
Protein dependency. Serum samples which were serially diluted also gave linear plots. This demonstrates that, in this assay, binding or precipitation characteristics are not altered by different sample protein concentrations. This is due to the high protein concentration of the plasma buffer. Thus there is no need to run a serum blank for nonspecific precipitation.
Comparison with other methods.
The accuracy of radioimmunoassays performed with the use of PEG was identical to that of the dextran-coated charcoal method used in the RIA kit marketed by New England Nuclear Corp. The precision of the PEG method was superior. Both procedures are identical through the incubation-with-antibody step. Then, in the case of the kit, charcoal is added and the reaction is incubated at room temperature for another 10 mm. The duration of incubation is relatively critical because it is an adsorptive method for separating free from antibody-bound hPL. In our method one can process more samples more rapidly because the time interval after addition of PEG and before centrifugation is not critical. Results are not affected even if one lets the tubes set for 30 mm or longer before centrifugation, because the antigen-antibody complex precipitates immediately.
The double-antibody method of Beck et al. (2) involves another incubation step with a second antibody to effect the separation of free from bound hPL. Hence, the time required for the assay is increased.
Rocket immunoelectrophoresis has also been used for the assay of serum hPL concentration (11 Antibody-bound hPL is completely precipitated with little nonspecific precipitation of free hPL. Virtually all radioactive hormone remaining in solution is unbound and there is no evidence for dissociation of antigen-antibody complexes upon addition of PEG. This method also avoids nonspecific effects of plasma and anticoagulants, which are ever present in double-antibody RIA methods.
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